pegvisomant  - Drug Details
📊 Estimates pegvisomant  Dialyzability By Different_Modalities

pegvisomant 

Complete Drug Information

Drug Name
pegvisomant 
Trade Names
Somavert
Pregnancy Category
AU: B3
Routes of Administration
Subcutaneous
Formula
C990H1532N262O300S7
Molar Mass
22129.1
Volume of Distribution
C990H1532N262O300S7

🤰 Pregnancy Category Information

Category: AU: B3

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.